Premium
Progression‐free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint?
Author(s) -
Becker Andreas,
Eichelberg Christian,
Sun Maxine
Publication year - 2013
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28378
Subject(s) - surrogate endpoint , medicine , clinical endpoint , progression free survival , endpoint determination , clinical trial , overall survival , survival analysis , intensive care medicine , oncology
In this editorial, the authors critically discuss the current role and limitations of progression‐free survival as a surrogate endpoint of overall survival in clinical trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom